Native Human IgA1 protein is a Human Full Length IgA1 protein with >95% purity and suitable for SDS-PAGE. The predicted molecular weight of ab91020 native protein is 160 kDa.
- Save time and ensure accurate results- use our native IgA1 protein as an isotype control
- No cross-reaction from other immunoglobulin isotypes
View Alternative Names
Immunoglobulin heavy constant alpha 1, Ig alpha-1 chain C region, Ig alpha-1 chain C region BUR, Ig alpha-1 chain C region TRO, IGHA1
- SDS-PAGE
Unknown
SDS-PAGE - Native Human IgA1 protein (AB91020)
SDS-PAGE : 4-12% Bis-Tris NuPAGE gel
1. 5 μg Human IgA1 (reduced /heated)
2. 10 μg Human IgA1 (reduced/ heated)
3. 20 μg Human IgA1 (reduced/ heated)
4. Molecular weight markers
5. 5 μg Human IgA1 (non-reduced/no heat)
6. 10 μg Human IgA1 (non-reduced/no heat)
7. 20 μg Human IgA1 (non-reduced/no heat)
Reactivity data
Product details
Ensure the validity of your result using our native human IgA1 protein as an isotype control in SDS-PAGE.
Check out our protein gel staining guide for SDS-PAGE here
Protein Determination: Extinction Coefficient (ε) 0.1% at 280 nm, 1cm pathway = 1.32
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IgA1 acts as a first line of defense in the immune system by binding to pathogens and neutralizing them. It exists as a monomer or forms a dimer with the help of the J chain which stabilizes its dimeric form. IgA1 also interacts with the polymeric immunoglobulin receptor (pIgR) for transportation across epithelial cells. This transport allows IgA1 to be present in secretory fluids such as saliva and breast milk providing an important protective function.
Pathways
IgA1 interacts with several pathways involved in immune response and mucosal immunity. One critical pathway is the mucosal antibody response where IgA1 plays a role in preventing infection at mucosal surfaces. The IgA1 protein activates the alternative complement pathway by binding to complement protein C3 which enhances the removal of pathogens. Furthermore IgA1 is associated with the J chain and pIgR in the process of IgA transcytosis across epithelial barriers.
Specifications
Form
Liquid
General info
Function
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Ig alpha is the major immunoglobulin class in body secretions (PubMed : 2241915).
Post-translational modifications
Isoform 1. 3-Hydroxykynurenine, an oxidized tryptophan metabolite that is common in biological fluids, reacts with alpha-1-microglobulin to form heterogeneous polycyclic chromophores including hydroxanthommatin. The chromophore reacts with accessible cysteines forming non-reducible thioether cross-links with Ig alpha-1 chain C region Cys-352.. N- and O-glycosylated. N-glycan at Asn-144: Hex5HexNAc4.
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Journal of cellular and molecular medicine 29:e70615 PubMed40418206
2025
Applications
Unspecified application
Species
Unspecified reactive species
Microbiology spectrum :e0245024 PubMed40130864
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2022:1740770 PubMed36388165
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:889008 PubMed35899112
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 9:881322 PubMed35836957
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 8:794962 PubMed34977095
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 12:712130 PubMed34804008
2021
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 5: PubMed32699192
2020
Applications
Unspecified application
Species
Unspecified reactive species
Maternal health, neonatology and perinatology 5:9 PubMed31205733
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com